Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Total Debt (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Total Debt for 3 consecutive years, with $18.9 million as the latest value for Q4 2025.

  • Quarterly Total Debt changed N/A to $18.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.9 million through Dec 2025, changed N/A year-over-year, with the annual reading at $18.9 million for FY2025, N/A changed from the prior year.
  • Total Debt hit $18.9 million in Q4 2025 for Rapid Micro Biosystems, roughly flat from $18.8 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $25.0 million in Q2 2021 to a low of $18.8 million in Q3 2025.